Skip to main content
Back to RA Capital Management

RA Capital Management's Product Research Portfolio

Browse 4 Product Research companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Product Research Companies
4
Total Funding in Product Research
$695.0M

Product Research Portfolio Companies (4)

Export
BiotechnologyMedicalProduct Research

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

San Francisco, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceOncologyProduct Research

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Cambridge, United States
August 2024
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyInformation TechnologyMedicalProduct Research

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Berkeley, United States
November 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

San Diego, United States
March 2026
$505.0M
Undisclosed

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio